Deutsche Bank’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
VCIM
VCM
SCM
ACA
IHAM
ACM
Deutsche Bank's TARA Position: Q1 2026 in Review
Deutsche Bank increased its Protara Therapeutics (TARA) stake by 115% in Q1 2026, buying an estimated $171K and bringing the position to 53,975 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.
Deutsche Bank first reported a position in TARA in Q4 2014 and has held it in 15 quarters since. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.
- Deutsche Bank held 53,975 shares of Protara Therapeutics worth $281K as of Q1 2026.
- Deutsche Bank bought 28,879 Protara Therapeutics shares in Q1 2026, an estimated $171K.
- Protara Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2854 holding.
- Deutsche Bank first reported a position in Protara Therapeutics in Q4 2014 and has held it in 15 quarters since.
- 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.